The cell therapy packaging market is rapidly evolving as advanced therapies transform the biopharmaceutical industry. The market is projected to grow from USD 419.57 million in 2025 to USD 1,140.32 million by 2034, expanding at a CAGR of 11.75% during the forecast period.

Cell therapy packaging plays a vital role in maintaining the viability and sterility of living cell-based therapies throughout their storage, transport, and distribution. The market’s robust expansion is driven by the accelerating commercialization of cell and gene therapies, increased investments in manufacturing infrastructure, and rising global demand for specialized cryogenic and temperature-controlled packaging solutions.

Market Overview

Cell therapy packaging encompasses the design, manufacturing, and supply of specialized primary, secondary, and tertiary packaging solutions tailored for autologous and allogeneic cell therapies, including CAR-T, stem cell, NK cell, and dendritic cell therapies. These solutions ensure sterility, cryogenic stability, traceability, and compliance with global Good Manufacturing Practices (GMP).

In 2024, the market was valued at approximately USD 375.45 million, with North America accounting for around 40% of the total share. The industry’s growth is supported by strong biopharmaceutical investments, regulatory support, and technological advancements in cryogenic systems and single-use materials.

Key Market Highlights:

  • Market Size in 2025: USD 419.57 million

  • Projected Market Size in 2034: USD 1,140.32 million

  • CAGR (2025-2034): 11.75%

  • Leading Region: North America (40% share)

  • Fastest-Growing Region: Asia Pacific

Download a Sample of Our Market Intelligence:  https://www.towardspackaging.com/download-sample/5873

Market Dynamics

Market Drivers

  1. Expansion of Cell and Gene Therapy Industry:
    The surge in FDA and EMA approvals of advanced therapies has significantly boosted demand for reliable packaging systems that preserve product integrity across manufacturing and delivery.

  2. Regulatory and Quality Compliance:
    Strict international GMP and GDP standards mandate the use of validated cryogenic packaging solutions to ensure safety and traceability of living cells.

  3. Rise in Autologous and Personalized Therapies:
    Increasing adoption of autologous therapies necessitates specialized, single-patient-specific packaging formats.

  4. Technological Advancements:
    Developments in cryogenic storage, single-use systems, and smart temperature monitoring technologies are revolutionizing the market.

  5. Growing Cold-Chain Infrastructure:
    Expansion of global cold-chain logistics networks has enabled the transportation of cell therapies under stringent temperature conditions, improving market scalability.

Market Restraints

  • High cost of specialized cryogenic packaging materials and systems.

  • Complex logistics requirements for temperature-sensitive biologics.

  • Regulatory differences between regions creating approval and compliance challenges.

Market Opportunities

  • Increasing collaborations between biotech manufacturers and logistics providers.

  • Rising investment in cell therapy research and manufacturing facilities across Asia Pacific.

  • Growing emphasis on smart packaging technologies for real-time monitoring and traceability.

Invest in Our Premium Strategic Solution: https://www.towardspackaging.com/checkout/5873

Market Segments

By Packaging Type

  • Primary Packaging (Cryovials, Cryobags, Cell Containers):
    This segment held the largest share (around 42% in 2024) due to its role in ensuring sterility, dosage accuracy, and long-term cryogenic stability. These containers, often made of medical-grade polypropylene, withstand ultra-low temperatures and minimize contamination risks.

  • Tertiary Packaging (Cryogenic Shippers, Overpacks, Bulk Systems):
    Expected to grow at the highest CAGR during 2025-2034, driven by the need for safe bulk transportation of temperature-sensitive products.

By Material Type

  • Cryogenic Plastics (Polypropylene, Polycarbonate, HDPE):
    Accounted for approximately 38% share in 2024. These materials are durable, contamination-resistant, and maintain integrity at liquid nitrogen temperatures.

  • Single-Use Polymer Films (EVA, Multilayer Films):
    Anticipated to record the fastest growth due to sterility, mechanical strength, and enhanced gas-barrier properties, supporting long-term storage of cell products.

By Function

  • Storage Packaging (Cryogenic Freezing & Long-Term Storage):
    Dominated the market in 2024 with about 36% share, reflecting the growing need for cryopreservation systems that ensure cell viability over time.

  • Transport Packaging (Cold Chain & Cryogenic Shipping):
    Expected to expand significantly, driven by the global distribution of clinical and commercial cell therapies.

By Cell Therapy Type

  • CAR-T Cell Therapies:
    Held the largest market share (around 34% in 2024) due to the strong clinical adoption and approvals in oncology treatments.

  • Stem Cell Therapies (MSC, iPSC, HSC):
    Projected to grow fastest between 2025 and 2034, owing to increasing clinical trials and the rising therapeutic potential of stem cells.

By End User

  • Cell Therapy Manufacturers / Biopharma Companies:
    Accounted for approximately 38% share in 2024, reflecting the growing demand for in-house packaging and logistics solutions for cell therapies.

  • Specialized Logistics & Cryo-Transport Companies:
    Anticipated to register the fastest CAGR as these organizations provide end-to-end cold-chain solutions, smart vessel tracking, and regulatory compliance management.

By Region

  • North America:
    Dominated the market with ~40% share in 2024 due to strong R&D activity, advanced manufacturing infrastructure, and extensive clinical trials.

  • Europe:
    Exhibits notable growth, supported by strict regulatory standards, research excellence, and an expanding ecosystem of CDMOs and biotech startups.

  • Asia Pacific:
    Forecast to witness the highest CAGR during 2025-2034, driven by increasing government investment, rising cancer prevalence, and expansion of clinical research centers in China, Japan, and India.

  • Latin America:
    Emerging as a promising region due to improving healthcare infrastructure and rising adoption of advanced therapies.

Submit Press Release for Packaging Industry and Innovations:

https://www.towardspackaging.com/press-release-solution

Top Companies in the Cell Therapy Packaging Market

Cryoport, Inc.

About: Cryoport is a leading global provider of temperature-controlled logistics and packaging solutions for cell and gene therapies.
Products: Cryogenic shippers, biostorage systems, and end-to-end logistics solutions that ensure product integrity during transport.
Market Cap: Approximately USD 440 million in 2025.

Thermo Fisher Scientific Inc.

About: Thermo Fisher is one of the largest life-science companies worldwide, serving pharmaceuticals, biotech, and clinical research sectors.
Products: CryoSolutions, Nalgene biopackaging systems, cold-chain storage systems, and laboratory consumables.
Market Cap: Approximately USD 216 billion in 2025.

Sartorius AG

About: Sartorius is a German biotechnology equipment manufacturer specializing in single-use bioprocessing technologies.
Products: Cryo-containment systems, single-use packaging, filtration and containment systems for biologics and cell therapies.
Market Cap: Approximately USD 17 billion in 2025.

Merck KGaA (MilliporeSigma)

About: Merck KGaA offers advanced biopharma-grade packaging, filtration, and cryogenic storage solutions supporting clinical and commercial manufacturing.
Products: Cryogenic vials, storage bottles, bioreactor consumables, and upstream processing packaging solutions.
Market Cap: Approximately USD 70 billion in 2025.

Corning Incorporated

About: Corning is a global leader in glass and ceramics technologies, active in producing lab consumables for bioprocessing.
Products: Cryogenic vials, cell culture systems, and single-use laboratory packaging materials.
Market Cap: Approximately USD 32 billion in 2025.

West Pharmaceutical Services

About: West Pharmaceutical designs and manufactures high-quality systems for injectable drug packaging and containment.
Products: Vials, stoppers, and seals compatible with cryogenic and biologic materials.
Market Cap: Approximately USD 28 billion in 2025.

SCHOTT AG

About: SCHOTT specializes in glass manufacturing and supplies high-precision packaging materials for the pharmaceutical industry.
Products: Tubular glass, ampoules, and vials for biologics and cryogenic applications.

Catalent Pharma Solutions

About: Catalent is a global CDMO providing manufacturing, packaging, and logistics for biologics, vaccines, and cell therapies.
Products: Cold-chain logistics, vial filling, and secondary packaging systems.
Market Cap: Approximately USD 8 billion in 2025.

Avantor, Inc.

About: Avantor supplies materials and consumables for laboratory and bioprocessing applications worldwide.
Products: Single-use systems, cryogenic bags, polymer films, and bioprocess containers.
Market Cap: Approximately USD 13 billion in 2025.

DWK Life Sciences

About: DWK manufactures glass and plastic containers, lab bottles, and cryogenic storage systems for life-sciences industries.
Products: Cryogenic tubes, vials, and custom glassware for temperature-controlled applications.

ArcticZyme Technologies ASA

About: ArcticZyme provides cold-chain biological materials and enzyme technologies for cryopreservation and packaging optimization.

CSafe Global

About: CSafe Global develops active and passive temperature-controlled containers and cryogenic shippers for life-science logistics.

Insight and Strategic Implications

The cell therapy packaging market is undergoing transformation driven by technological innovation, rising demand for personalized therapies, and stricter regulatory environments. Companies are focusing on automation, modularity, and smart packaging to enhance efficiency and reduce contamination risks.

Key Insights:

  • Smart cryogenic vessels with digital monitoring will become mainstream.

  • Integration of blockchain-based traceability systems will improve supply-chain transparency.

  • Sustainability and material innovation will become a key differentiator.

  • Partnerships between packaging companies and therapy manufacturers will grow, enabling faster market scalability.

  • Asia Pacific’s entry into large-scale cell therapy manufacturing will reshape the supply chain, creating demand for localized packaging solutions.

Conclusion

The cell therapy packaging market is poised for robust expansion, supported by the evolution of regenerative medicine and the growing need for precise, compliant, and secure packaging systems. The industry will grow from USD 419.57 million in 2025 to USD 1,140.32 million by 2034, reflecting a CAGR of 11.75%.

North America leads with strong R&D investments, but Asia Pacific will emerge as a high-growth hub due to expanding clinical infrastructure. Companies such as Thermo Fisher Scientific, Sartorius AG, Cryoport, and Merck KGaA are well-positioned to capitalize on this growth by offering comprehensive, technology-driven solutions.

As the global shift toward personalized medicine intensifies, the importance of specialized, cryogenic, and intelligent packaging for living cells will continue to rise, making cell therapy packaging a cornerstone of next-generation biopharmaceutical logistics.

Frequently Asked Questions

1. What is the size of the cell therapy packaging market?
The market was valued at approximately USD 419.57 million in 2025 and is projected to reach USD 1,140.32 million by 2034, growing at a CAGR of 11.75%.

2. Which region holds the largest market share?
North America dominates the global market with about 40% share due to its strong biopharma infrastructure and R&D investment.

3. Which segment is expected to grow the fastest?
The tertiary packaging segment, focused on cryogenic shipping systems, is expected to grow at the highest CAGR between 2025 and 2034.

4. What are the main materials used in cell therapy packaging?
Key materials include cryogenic plastics such as polypropylene and HDPE, along with single-use polymer films like EVA and multilayer structures.

5. Who are the leading players in the market?
Major players include Cryoport, Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Corning, West Pharmaceutical Services, Catalent, and Avantor, among others.

Source : https://www.towardspackaging.com/insights/cell-therapy-packaging-market-sizing

Access our exclusive, data-rich dashboard dedicated to the respective market built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access Now: https://www.towardspackaging.com/contact-us

Become a Valued Research Partner with Us - Schedule a meeting: https://www.towardspackaging.com/schedule-meeting

Request a Custom Case Study Built Around Your Goals: sales@towardspackaging.com

About Us

Towards Packaging is a global consulting and market intelligence firm specializing in strategic research across key packaging segments including sustainable, flexible, smart, biodegradable, and recycled packaging. We empower businesses with actionable insights, trend analysis, and data-driven strategies. Our experienced consultants use advanced research methodologies to help companies of all sizes navigate market shifts, identify growth opportunities, and stay competitive in the global packaging industry.

Stay Connected with Towards Packaging:

  • Contact: APAC: +91 9356 9282 04 | Europe: +44 778 256 0738 | North America: +1 8044 4193 44

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Healthcare |TowardsAuto | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics